Guilin Sanjin Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 516.89 million compared to CNY 429.59 million a year ago. Revenue was CNY 516.89 million compared to CNY 429.59 million a year ago. Net income was CNY 120.05 million compared to CNY 97.67 million a year ago.